Edwards Lifesciences Corporation
EWLast close · Oct 16, 202686.60−1.50 (−1.70%)
Market cap$49.9B
Between Jun 17, 2026 and Oct 8, 2026, Edwards Lifesciences (EW) insiders filed 40 Form 4 transactions: 14 sales worth $4.7M in total and no open-market purchase; 6 of the sales were under 10b5-1 plans set in advance. The largest seller was Chopra Daveen, $2.8M. 26 other filings were grants, exercises or gifts, which say nothing about buying or selling.
40
0
14
16
Form 4 transactions
| Date | Insider | Title | Code | Plan | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| 2026-10-08 | Lippis Daniel J. | CVP, TAVR | M | 10b5-1 | 619 | 0.00 | $0 |
| 2026-10-08 | Lippis Daniel J. | CVP, TAVR | S | 10b5-1 | 619 | 85.65 | $53,017.4 |
| 2026-10-08 | Lippis Daniel J. | CVP, TAVR | M | 10b5-1 | 619 | 72.68 | $44,988.9 |
| 2026-09-11 | Markowitz Wayne | CVP, JAPAC | F | 355 | 86.77 | $30,803.4 | |
| 2026-09-14 | Markowitz Wayne | CVP, JAPAC | F | 568 | 84.37 | $47,922.2 | |
| 2026-09-13 | Dahl Andrew M. | SVP, Corporate Controller | F | 253 | 84.37 | $21,345.6 | |
| 2026-09-11 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | F | 398 | 86.77 | $34,534.5 | |
| 2026-09-11 | Lippis Daniel J. | CVP, TAVR | M | 10b5-1 | 619 | 72.68 | $44,988.9 |
| 2026-09-11 | Lippis Daniel J. | CVP, TAVR | S | 10b5-1 | 619 | 87.51 | $54,168.7 |
| 2026-09-11 | Lippis Daniel J. | CVP, TAVR | M | 10b5-1 | 619 | 0.00 | $0 |
| 2026-08-31 | Dahl Andrew M. | SVP, Corporate Controller | S | 544 | 91.06 | $49,533.9 | |
| 2026-08-28 | Bruls Annette | CVP, EMEACLA | S | 2,644 | 89.98 | $237,907.1 | |
| 2026-08-26 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | M | 31,800 | 72.68 | $2.3M | |
| 2026-08-26 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | S | 1,154 | 91.76 | $105,892.7 | |
| 2026-08-26 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | S | 30,646 | 90.99 | $2.8M | |
| 2026-08-26 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | M | 31,800 | 0.00 | $0 | |
| 2026-08-26 | Markowitz Wayne | CVP, JAPAC | S | 1,240 | 91.47 | $113,416.6 | |
| 2026-08-11 | Lippis Daniel J. | CVP, TAVR | M | 10b5-1 | 619 | 72.68 | $44,988.9 |
| 2026-08-11 | Lippis Daniel J. | CVP, TAVR | S | 10b5-1 | 619 | 92.03 | $56,966.6 |
| 2026-08-11 | Lippis Daniel J. | CVP, TAVR | M | 10b5-1 | 619 | 0.00 | $0 |
| 2026-07-30 | Markowitz Wayne | CVP, JAPAC | S | 146 | 86.03 | $12,587.8 | |
| 2026-07-28 | Markowitz Wayne | CVP, JAPAC | M | 9,628 | 74.02 | $712,664.6 | |
| 2026-07-28 | Markowitz Wayne | CVP, JAPAC | S | 9,628 | 85.06 | $818,957.7 | |
| 2026-07-28 | Markowitz Wayne | CVP, JAPAC | M | 9,628 | 0.00 | $0 | |
| 2026-07-27 | Zovighian Bernard J | CEO | G | 320 | 0.00 | $0 | |
| 2026-07-27 | Zovighian Bernard J | CEO | G | 320 | 0.00 | $0 | |
| 2026-07-27 | Zovighian Bernard J | CEO | S | 2,921 | 83.93 | $245,134.1 | |
| 2026-07-11 | Bruls Annette | CVP, EMEACLA | F | 109 | 92.21 | $10,050.9 | |
| 2026-07-09 | Mistras Theodora | CVP, Chief Financial Officer | A | 87,595 | 0.00 | $0 | |
| 2026-07-09 | Mistras Theodora | CVP, Chief Financial Officer | A | 12,325 | 0.00 | $0 | |
| 2026-07-09 | Mistras Theodora | CVP, Chief Financial Officer | A | 61,800 | 0.00 | $0 | |
| 2026-07-09 | Mistras Theodora | CVP, Chief Financial Officer | A | 12,325 | 0.00 | $0 | |
| 2026-07-10 | Lippis Daniel J. | CVP, TAVR | M | 10b5-1 | 619 | 72.68 | $44,988.9 |
| 2026-07-10 | Lippis Daniel J. | CVP, TAVR | S | 10b5-1 | 619 | 91.70 | $56,762.3 |
| 2026-07-10 | Lippis Daniel J. | CVP, TAVR | M | 10b5-1 | 619 | 0.00 | $0 |
| 2026-07-07 | Lippis Daniel J. | CVP, TAVR | F | 377 | 95.18 | $35,882.9 | |
| 2026-06-30 | Lippis Daniel J. | CVP, TAVR | M | 10b5-1 | 619 | 72.68 | $44,988.9 |
| 2026-06-30 | Lippis Daniel J. | CVP, TAVR | S | 10b5-1 | 619 | 91.40 | $56,576.7 |
| 2026-06-30 | Lippis Daniel J. | CVP, TAVR | M | 10b5-1 | 619 | 0.00 | $0 |
| 2026-06-17 | Zovighian Bernard J | CEO | S | 10b5-1 | 523 | 87.92 | $45,982.2 |
Codes are the SEC's: P open-market purchase, S open-market sale; M exercise, F tax withholding, A grant and G gift are routine. A 10b5-1 flag means the trade ran under a plan adopted in advance. Method notes in where the numbers come from.